July 1, 2015 — Nationally renowned physician and scientist Dr. Howard Federoff has joined the University of California, Irvine as vice chancellor for health affairs and dean of the School of Medicine.
Federoff, a groundbreaking investigator for neurological disorders, is responsible for overseeing UC Irvine Health and the School of Medicine.
He will provide strategic guidance over the clinical programs of UC Irvine Medical Center and all affiliated UC Irvine Health patient care centers, and ensure the alignment of the clinical enterprise and physicians’ practice with the university’s academic and research missions.
He also will direct the development and integration of UC Irvine health-related academic programs in nursing science, public health and pharmaceutical sciences.
Federoff comes to UC Irvine from Georgetown University, where he served as executive vice president for health sciences and executive dean of the school of medicine. During his tenure at Georgetown, he is credited with advancing the educational and research missions of Georgetown University Medical Center and working effectively with the leadership of MedStar Health, its clinical partner. GUMC is a $274-million biomedical research and educational organization that accounts for more than 85 percent of the university’s sponsored research funding.
As vice chancellor and dean, Federoff also will play a key role in advancing philanthropic activities and community and industry partnerships for UC Irvine Health.
He believes that patient-centered prevention, wellness and healthcare delivery is powered by the most compelling science. a case he can make from personal experience. He is the lead author of a 2014 study — which included UC Irvine researchers — that discovered and validated a predictive blood test for those at risk for Alzheimer’s disease.
Federoff received PhD and MD degrees from the Albert Einstein College of Medicine in New York, and completed internship, residency, clinical and research fellowships at Massachusetts General Hospital and Harvard Medical School. He held clinical and academic posts at Einstein and the University of Rochester School of Medicine, before joining Georgetown in 2007.
Board-certified in internal medicine as well as endocrinology and metabolism, Federoff also has advanced research in the areas of gene therapy and neurodegenerative disorders such as Alzheimer's, Parkinson’s and prion diseases. He holds a number of medical patents, with several other patents pending.
He replaces Dr. Roger Steinert, the Irving H. Leopold Chair in Ophthalmology and director of the Gavin Herbert Eye Institute, who served as interim dean of the School of Medicine after Dr. Ralph V. Clayman retired from the position in July 2014.